Breaking News Instant updates and real-time market news.

NEM

Newmont Goldcorp

$37.80

-0.17 (-0.45%)

17:01
10/22/19
10/22
17:01
10/22/19
17:01

Newmont Goldcorp starting production at Penasquito Mine in Mexico

Newmont Goldcorp is safely starting up production at the Penasquito mine in Mexico following the lifting of the illegal blockade on October 8. With the support of the State and Federal governments, including an ongoing police presence, the company has commenced an approximately 10-day process of bringing back the operation to full production.

  • 05

    Nov

NEM Newmont Goldcorp
$37.80

-0.17 (-0.45%)

09/12/19
MACQ
09/12/19
INITIATION
MACQ
Neutral
Newmont Goldcorp initiated with a Neutral at Macquarie
Macquarie analyst Danielle Chigumira initiated Newmont Goldcorp with a Neutral rating rating.
10/03/19
DBAB
10/03/19
UPGRADE
Target $45
DBAB
Buy
Newmont Goldcorp upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Chris Terry upgraded Newmont Goldcorp to Buy from Hold with a price target of $45.
10/03/19
DBAB
10/03/19
UPGRADE
Target $45
DBAB
Buy
Deutsche Bank upgrades Newmont Goldcorp to Buy after underperformance
Deutsche Bank analyst Chris Terry upgraded Newmont Goldcorp (NEM) to Buy from Hold and raised his price target for the shares to $45 from $44. Shares of Newmont have significantly underperformed compared to its closest peer Barrick Gold (GOLD) and also versus the gold price, Terry tells investors in a research note. The analyst, who remains positive on gold, believes Newmont's headwinds are bottoming and that the stock is attractive at current levels.
10/03/19
10/03/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Raytheon (RTN) upgraded to Outperform from Neutral at Credit Suisse WITH analyst Robert Spingarn saying he believes United Technologies' (UTX) aerospace businesses are undervalued and that the market has yet to appropriately discount Raytheon's ~43.1% ownership of the proposed combined entity. 2. Wipro (WIT) upgraded to Neutral from Sell at Goldman Sachs with analyst Sumeet Jain citing valuation. 3. Dova Pharmaceuticals (DOVA) upgraded to Neutral from Underweight at JPMorgan with analyst Joel Fishbein saying the company's "strong" execution continues to drive "impressive growth at scale" as customer deal sizes grow amid larger initial deployments and customers adopting multiple products. 4. Crowdstrike (CRWD) upgraded to Buy from Hold at SunTrust with analyst Joel Fishbein saying the company has developed a "category-defining" cloud platform for cyber security, a market that is "ripe for disruption." 5. Newmont Goldcorp (NEM) upgraded to Buy from Hold at Deutsche Bank with analyst Chris Terry saying shares of Newmont have significantly underperformed compared to its closest peer Barrick Gold (GOLD) and also versus the gold price. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

HURN

Huron

$69.15

0.23 (0.33%)

13:57
12/12/19
12/12
13:57
12/12/19
13:57
Conference/Events
Huron management to meet with Benchmark »

Group Luncheon Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

13:55
12/12/19
12/12
13:55
12/12/19
13:55
Conference/Events
The FDIC to hold a Board Meeting »

Board of Directors…

MLNT

Melinta Therapeutics

$1.71

0.15 (9.62%)

13:48
12/12/19
12/12
13:48
12/12/19
13:48
Hot Stocks
FDA approves Melinta Therapeutics sNDA for Orbactiv for injection »

A letter posted by the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTWO

Take-Two

$122.30

-0.08 (-0.07%)

13:45
12/12/19
12/12
13:45
12/12/19
13:45
Options
TakeTwo Interactive Software call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 13

    Dec

KW

Kennedy Wilson

$22.26

-0.25 (-1.11%)

13:44
12/12/19
12/12
13:44
12/12/19
13:44
Hot Stocks
Kennedy Wilson raises quarterly dividend 5% to 22c per share »

Kennedy Wilson announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

SPY

SPDR S&P 500 ETF Trust

$316.35

1.94 (0.62%)

, SPX

S&P 500

$0.00

(0.00%)

13:38
12/12/19
12/12
13:38
12/12/19
13:38
Periodicals
WH Press Secretary says President to hold trade meeting at 2:30, CNBC reports »

CNBC political reporter…

SPY

SPDR S&P 500 ETF Trust

$316.35

1.94 (0.62%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GILD

Gilead

$67.62

0.48 (0.71%)

13:36
12/12/19
12/12
13:36
12/12/19
13:36
Periodicals
PrEP4All says USPTO adviser showed 'bias' in favor of Gilead, STAT reports »

An AIDS activist group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCS

Barclays

$8.98

0.01 (0.11%)

13:35
12/12/19
12/12
13:35
12/12/19
13:35
Options
Barclays put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$11.37

0.385 (3.51%)

13:20
12/12/19
12/12
13:20
12/12/19
13:20
Options
Largest trade of the day is a Jan 2021 GE 1x3 totalling 108K contracts »

Largest trade of the day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

13:20
12/12/19
12/12
13:20
12/12/19
13:20
General news
Treasury's $16 B 30-year bond reopening was very, very well received »

Treasury's $16 B…

HIIQ

Health Insurance Innovations

$19.23

0.88 (4.80%)

13:17
12/12/19
12/12
13:17
12/12/19
13:17
Recommendations
Health Insurance Innovations analyst commentary  »

Health Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
12/12/19
12/12
13:17
12/12/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
12/12/19
12/12
13:16
12/12/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:08
12/12/19
12/12
13:08
12/12/19
13:08
General news
30-Yr Bond Auction Coupon Rate data reported »

30-Yr Bond Auction Coupon…

13:08
12/12/19
12/12
13:08
12/12/19
13:08
General news
30-Yr Bond Auction Total Amount data reported »

30-Yr Bond Auction Total…

INSG

Inseego

$7.67

0.24 (3.23%)

13:05
12/12/19
12/12
13:05
12/12/19
13:05
Options
Inseego call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRX

Amneal Pharmaceuticals

$5.16

1.675 (48.06%)

13:00
12/12/19
12/12
13:00
12/12/19
13:00
Recommendations
Amneal Pharmaceuticals analyst commentary  »

Amneal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRTX

Vertex

$219.47

-0.59 (-0.27%)

, PTI

Proteostasis

$4.01

-0.23 (-5.42%)

12:55
12/12/19
12/12
12:55
12/12/19
12:55
Conference/Events
Cantor Fitzgerald biotech analysts to hold an analyst/industry conference call »

Biotechnology Analysts…

VRTX

Vertex

$219.47

-0.59 (-0.27%)

PTI

Proteostasis

$4.01

-0.23 (-5.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 19

    Mar

ADBE

Adobe

$304.30

0.55 (0.18%)

, AVGO

Broadcom

$324.00

4.14 (1.29%)

12:53
12/12/19
12/12
12:53
12/12/19
12:53
Earnings
Notable companies reporting after market close »

Notable companies…

ADBE

Adobe

$304.30

0.55 (0.18%)

AVGO

Broadcom

$324.00

4.14 (1.29%)

COST

Costco

$295.82

0.6 (0.20%)

ORCL

Oracle

$56.16

-0.15 (-0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

  • 12

    Dec

  • 12

    Dec

  • 23

    Jan

12:50
12/12/19
12/12
12:50
12/12/19
12:50
General news
U.S. Household net worth rose »

U.S. Household net worth…

12:50
12/12/19
12/12
12:50
12/12/19
12:50
General news
Treasury Action: yields remain near their highs of the sessio »

Treasury Action: yields…

CC

Chemours

$17.55

0.955 (5.75%)

12:45
12/12/19
12/12
12:45
12/12/19
12:45
Options
Chemours call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:41
12/12/19
12/12
12:41
12/12/19
12:41
Hot Stocks
Breaking Hot Stocks news story  »

Liberty TripAdvisor…

12:36
12/12/19
12/12
12:36
12/12/19
12:36
Hot Stocks
Breaking Hot Stocks news story  »

Liberty TripAdvisor…

PBYI

Puma Biotechnology

$8.89

0.18 (2.07%)

12:32
12/12/19
12/12
12:32
12/12/19
12:32
Hot Stocks
Puma Biotechnology: plasmaMATCH trial shows neratinib activity in ERBB2 cancer »

Puma Biotechnology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.